Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're unemployed and wondering whether weight loss injections are within reach, the short answer is that employment status plays no role in clinical eligibility. Licensed medicines like Mounjaro and Wegovy are prescription-only treatments assessed on your health profile — your BMI, your medical history, and any weight-related conditions — not your work situation. What does matter is whether you can access them through the NHS at this stage, or whether a private regulated pharmacy is the route that makes sense for you right now. These are serious medicines that require a prescription following a clinical assessment; a prescriber, not an algorithm, decides suitability. What follows is an honest account of the landscape, so you can make an informed decision without having to dig through conflicting information online.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Employment status is not a clinical variable. Neither the licensed criteria in the SmPC nor the NICE recommendations for Mounjaro or Wegovy make any reference to whether someone works. What the guidance does focus on is body mass index and the presence of weight-related health conditions such as high blood pressure, type 2 diabetes, obstructive sleep apnoea, high cholesterol or cardiovascular disease.
For Mounjaro, NICE TA1026 recommends it for adults with a BMI of 35 or above alongside at least one qualifying weight-related condition, with lower BMI thresholds applying for people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds. The private licensed threshold sits lower, a BMI of 30 or above, or 27 or above with at least one weight-related condition. You can read more about how those numbers translate into practice on our guide to weight thresholds for weight loss injections.
Semaglutide (Wegovy) follows similar lines under NICE TA875. In both cases, a prescriber assesses the whole picture: not just the number on the scales but your broader health, your medication history, and any contraindications. That assessment happens regardless of what you do (or don't do) for work. Our clinical team review every consultation personally; it is a clinical conversation, not a form-sifting exercise.
NHS access to these medicines is real, but the eligibility bar is currently high. Under the phased rollout guided by NICE TA1026 and NHS England's interim commissioning framework, tirzepatide became available to NHS patients with a BMI of 40 or above and four or more of the five qualifying conditions from June 2025. A second cohort (BMI 35 to 39.9 with four or more conditions) became eligible from June 2026. Further cohorts are expected around March 2027.
There is an important practical point here. Even if you meet the criteria on paper, GP practices opted into the new prescribing contract voluntarily, so access varies by area. You also need to take part in structured diet and activity support as part of the NHS package. If you're unemployed and already receiving certain benefits, your GP surgery is still the right first port of call, but prepare for the possibility that criteria, capacity, and local provision may not align immediately.
NHS England's guidance on weight management injections sets this out clearly. It is worth reading before your GP appointment, so you know what to ask.
This is probably where the honest difficulty sits for many people reading this. If you're unemployed, cost matters. Private weight loss injections are not cheap. The list price for Mounjaro rose significantly from September 2025, reported prices across providers now typically range from around £149 to £375 a month depending on the dose and the pharmacy.
There is no means-testing for private prescriptions, which means the route is open to you regardless of employment, but the price is the same regardless too. Some people also ask whether adjunct options such as B6 injections for weight loss might sit alongside or reduce the cost of a full programme, and it is worth discussing that with a prescriber. A private prescription for a controlled medicine is not something that should be cut on cost by going to unverified sellers, the MHRA has warned clearly about counterfeit weight loss pens circulating online, some of which have caused serious harm. Any legitimate price should include clinical assessment, a valid prescription, and dispensing through a pharmacy you can verify on the GPhC register at pharmacyregulation.org.
If you're weighing up whether private treatment is financially realistic, it helps to know what a single transparent price should cover, on our guide to the cost of weight loss injections we break down what headline prices typically include and what they sometimes leave out.
If you think you may meet NHS criteria, contact your GP first. Bring your BMI, your list of health conditions, and the NHS England guidance so the conversation is grounded in fact. If NHS criteria don't yet apply to your situation, or the wait is measured in months and your health picture means acting sooner makes sense, a private route through a properly registered pharmacy is a legitimate option, the clinical bar is the same, and employment status remains irrelevant to the prescriber's assessment.
You can explore how the different injectable weight management medicines work and compare their licensed indications before your consultation, including combination approaches such as the M injection for weight loss, which some people find useful to understand alongside the better-known branded options. It is also worth checking which weight loss injections are currently available in the UK and what their clinical evidence looks like, so you arrive at any consultation (NHS or private) with a clear sense of what you're asking about.
If you'd like to check whether you'd be eligible for treatment through our pharmacy, start a free consultation. A GPhC-registered prescriber reads every submission the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.